Pharmaceutical Firm

Digital Vision Pharma

Natco Pharma Q1 Net Profit Rises 31.2% To Rs 420.3 Cr

BY PTI

Tablets

Lupin Gets Tentative USFDA Nod For Dolutegravir, Emtricitabine And Tenofovir Alafenamide Tablets

BY Press Trust of India

Lupin Gets USFDA Nod For Generic Drug

BY Press Trust of India

Aurobindo Pharma Profit Falls 28% To Rs 576 Crore In March Quarter

Aurobindo Pharma Profit Falls 28% To Rs 576 Crore In March Quarter

BY PTI

Dr Reddys PAT Down 76% At Rs 87.5 Crore In March Quarter

Dr Reddy's PAT Down 76% At Rs 87.5 Crore In March Quarter

BY Press Trust of India

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

Sun Pharma Gets Form 483 From USFDA For Regulatory Violations At Halol Plant

BY PTI

Glenmark Gets Tentative Approval From USFDA For Generic Psoriasis Foam

Glenmark Gets Tentative Approval From USFDA For Generic Psoriasis Foam

BY PTI

Advertisement

Pharmaceutical Sector

Alembic Subsidiary Gets USFDA Nod For Plaque Psoriasis Treatment Foam

BY PTI

File Photo.

Lupin Launches Generic Contraceptive Drug In The US

BY Press Trust of India

File Photo.

Lupin Acquires Portfolio Of Brands From Anglo-French Drugs & Industries

BY Press Trust of India

Alembic Pharma has received 23 approvals year to date.

Alembic Pharma Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

These are generic versions of Vimpat tablets of the corresponding strengths of UCB, Inc.

Glenmark Pharmaceuticals Gets USFDA Nod For Lacosamide Tablet

BY Press Trust of India

Pharmaceutical Sector.

Piramal Pharma Ropes In Ajay Devgn For Brand Tetmosol

BY Press Trust of India

The US market for colchicine tablets USP, 0.6 mg is stood at around $85 million.

Strides Pharma Unit Gets USFDA For Generic Product

BY Press Trust of India

Advertisement

Following this development Biocon shares fell as much as 8 per cent to hit an intraday low of Rs 362

Biocon To Acquire Viatris' Biosimilar Assets For Up To $3.335 Billion

BY Outlook Business Team

India exported over $181 million worth of pharmaceutical goods to Ukraine in FY 21.

Indian Pharma Exporters In Wait And Watch Mode As Russia Invades Ukraine

BY PTI

J&J saw sales of its blood cancer treatment Darzalex jump 31 per cent to about $1.65 billion.

Prescription Drugs, Medical Devices Boost Johnson&Johnson Sales In Q4

BY AP

Cipla had posted a consolidated PAT of Rs 748 crore in the December quarter of 2020-21 fiscal.

Cipla's PAT Dips By 2.6% To Rs 729 Crore In December Quarter

BY PTI